Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · March 21, 2023

Adverse Pregnancy Outcomes After Treatment With Artemisinin Derivatives vs Non-Artemisinin Antimalarials in the First Trimester

The Lancet

 

Additional Info

The Lancet
Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis
Lancet 2023 Jan 14;401(10371)118-130, M Saito, R McGready, H Tinto, T Rouamba, D Mosha, S Rulisa, S Kariuki, M Desai, C Manyando, EM Njunju, E Sevene, A Vala, O Augusto, C Clerk, E Were, S Mrema, W Kisinza, J Byamugisha, M Kagawa, J Singlovic, M Yore, AM van Eijk, U Mehta, A Stergachis, J Hill, K Stepniewska, M Gomes, PJ Guérin, F Nosten, FO Ter Kuile, S Dellicour

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading